共 43 条
[1]
Chung H(2010)Changing trends in hepatitis C infection over the past 50 years in Japan Intervirology 53 39-43
[2]
Ueda T(2014)EASL clinical practice guidelines: management of hepatitis C virus infection J Hepatol 60 392-420
[3]
Kudo M(2014)Hepatitis C, a global issue: access to care and new therapeutic and preventive approaches in resource-constrained areas Semin Liver Dis 34 89-97
[4]
Lemoine M(2014)Simeprevir with peginterferon/ribavirin for treatment-naive hepatitis C genotype 1 patients in Japan: CONCERTO-1, a phase III trial J Hepatol 61 219-227
[5]
Thursz M(2012)Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in Japan J Hepatol 56 78-84
[6]
Hayashi N(2014)Once-daily simeprevir (TMC435) with peginterferon/ribavirin for treatment-naive hepatitis C genotype 1-infected patients in Japan: the DRAGON study J Gastroenterol 49 138-147
[7]
Izumi N(2013)Guidelines for the management of hepatitis C virus infection: first edition, May 2012, the Japan Society of Hepatology Hepatol Res 43 1-34
[8]
Kumada H(2014)JSH guidelines for the management of hepatitis C virus infection: a 2014 update for genotype 1 Hepatol Res 44 59-70
[9]
Kumada H(2014)Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection Hepatology 59 2083-2091
[10]
Toyota J(2010)Discovery of vaniprevir (MK-7009), a macrocyclic hepatitis C virus NS3/4a protease inhibitor J Med Chem 53 2443-2463